about
Efficacy and safety of ablation for patients with non-paroxysmal atrial fibrillationAtrial fibrillation in Sub-Saharan Africa: epidemiology, unmet needs, and treatment optionsInternational Collaborative Partnership for the Study of Atrial Fibrillation (INTERAF): Rationale, Design, and Initial DescriptivesGenetic mutations in African patients with atrial fibrillation: Rationale and design of the Study of Genetics of Atrial Fibrillation in an African Population (SIGNAL)Cardiovascular disease in Africa: epidemiological profile and challenges.Atrial fibrillation: the current epidemicNonalcoholic Fatty Liver Disease (NAFLD) and Risk of Cardiac Arrhythmias: A New Aspect of the Liver-heart Axis.Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction.Treatment Planning Studies in Patient Data With Scanned Carbon Ion Beams for Catheter-Free Ablation of Atrial Fibrillation.Efficacy and safety of warfarin in dialysis patients with atrial fibrillation: a systematic review and meta-analysis.Novel non-invasive algorithm to identify the origins of re-entry and ectopic foci in the atria from 64-lead ECGs: A computational study.Atrial fibrillation: prevalence in a large database of primary care patients in Brazil.Predictors and long-term clinical outcomes of newly developed atrial fibrillation in patients with cardiac implantable electronic devices.Association of Atrial Fibrillation and Cancer.Assessing bleeding risk in 4824 Asian patients with atrial fibrillation: The Beijing PLA Hospital Atrial Fibrillation ProjectThe risk of atrial fibrillation in patients with gout: a nationwide population-based study.Geographic variations in the PARADIGM-HF heart failure trial.Major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban or warfarin: a "real-world" observational study in the United StatesEmergency Department Readmission in Elderly Patients After Acute Rhythm or Rate Control Treatment for Atrial Fibrillation.A major role for cardiovascular burden in age-related cognitive decline.New approaches to managing nonvalvular atrial fibrillation: what are the thromboembolic implications?Efficacy and safety of rivaroxaban in real-life patients with atrial fibrillation.Impact of sex and ethnicity on arrhythmic risk.Clinical development of rivaroxaban: emerging new clinical evidences?Seeing the rural healthcare journeys of older adults with atrial fibrillation through a photographic lens.Interatrial septum versus right atrial appendage pacing for prevention of atrial fibrillation : A meta-analysis of randomized controlled trials.Hyperuricemia is associated with an increased prevalence of paroxysmal atrial fibrillation in patients with type 2 diabetes referred for clinically indicated 24-h Holter monitoring.Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?Ion channels, long QT syndrome and arrhythmogenesis in ageing.Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosisUse of direct oral anticoagulants in patients with nonvalvular atrial fibrillation according to clinical profile.Analysis of Circulating miR-1, miR-23a, and miR-26a in Atrial Fibrillation Patients Undergoing Coronary Bypass Artery Grafting Surgery.The impact of ischaemic stroke on atrial fibrillation-related healthcare cost: a systematic review.'What else can I do?': Insights from atrial fibrillation patient communication online.Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Clinical Practice.Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation.Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study.
P2860
Q24186195-AF0395F0-351B-475C-955E-0855E975305CQ26799571-8D85F4B0-0C15-4A9C-97B9-F94BC18C4EF7Q28584460-8358C2BB-93B4-4D0B-B2BE-A976CA97433CQ28607469-FF92A8E0-49A1-4BB0-826D-ACEF407C2218Q30235596-E8AC9FDE-AB57-400F-AFB6-2006D082A9C1Q33766896-72E9CF45-9156-4414-901A-0749B2D085CCQ33805278-DD983C3D-A4FF-4817-BEF9-BF2911BDA1CAQ33821854-9060E1F6-A9BC-4585-B4AA-CDDFEE64116BQ35686992-53F85384-8D49-4754-A8DB-171414F6170FQ35861669-430B5487-9D7C-4FDE-B11C-7DC0C8C99C78Q36069462-49DD456F-71FD-4E81-BDCE-AF7714DFDD46Q36295154-7259482A-97D0-4D39-B91F-7C38D8057399Q36428822-711103DA-9463-43ED-838D-CFE5F1B613B9Q37116854-241FE3D8-FCEC-47F6-9CD0-5EBF1035AC4CQ37118910-E346A87F-922B-424E-B445-E5D7058716E2Q37202504-94E542D8-0836-476A-91DC-5C1F196F9291Q37236227-C9D0F0A0-8671-449A-8023-BFB51456F19CQ37410283-D8F8961D-D8A9-434B-B50E-60F5E0C90118Q37456586-A0832AA2-E686-499B-BCDB-424699DAADDFQ37456935-A1977EC3-EC16-4C6C-87BA-9D8B0BC910F3Q38316448-EEFE34FC-03DE-4841-BF1A-2CAA9F3242A5Q38343151-7243E020-C13A-412E-AEB0-A470198AE2A1Q38386998-9F3A5429-812C-4CA7-9B37-4696214F552FQ38508942-8960E14D-7BD2-412F-9A35-539E2FD5BB48Q38537785-7187B59A-3A3B-45BC-9015-9E60AB5B5639Q38559132-EB9E0105-ED07-400B-AF7B-8ED510C5C68EQ38654249-4E90779D-5D13-41E0-8AB9-C0D00A2378A8Q38677229-DF66CD3C-7731-4236-8C43-3EBE09434892Q38711424-B533D1DB-FE9A-4F42-A5EC-3B2F03124F83Q38728028-5BFC2B7F-B221-4439-A8A3-926ECB012306Q38778017-4876F11A-4924-45E3-A1B9-5FBD198AD33FQ38800244-6F3E71CB-EEE4-48F5-926A-19713C7AA69FQ38812464-95214AB6-242A-4712-ADD3-1B2C01B51133Q38830818-1B7DD46C-5EEB-4458-BBEA-597E375E0679Q38840977-18429575-8F4A-409B-AD80-12BAA3BC6C76Q38940342-0D2FD0D5-AD9F-43FC-9CEA-4ACA27AC20BAQ38953655-AEF7C1A2-E423-4885-AF6A-F3B28A40C968Q39015608-4D3DA67C-32B8-4077-A0F7-9471CD7DBB0AQ39031152-FC5D982A-673C-4CF2-AD23-DE54CE3B385FQ39501461-FC4915E9-9B39-4466-908B-C1980C448DD0
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Global epidemiology of atrial fibrillation.
@ast
Global epidemiology of atrial fibrillation.
@en
type
label
Global epidemiology of atrial fibrillation.
@ast
Global epidemiology of atrial fibrillation.
@en
prefLabel
Global epidemiology of atrial fibrillation.
@ast
Global epidemiology of atrial fibrillation.
@en
P1476
Global epidemiology of atrial fibrillation.
@en
P2093
Faisal Rahman
P304
P356
10.1038/NRCARDIO.2014.118
P407
P577
2014-08-12T00:00:00Z